Search

everythinglearnresearchcommunity

for

Search:↓

The man was diagnosed with Cronkhite-Canada syndrome, a rare disorder with GI polyps, skin issues, hair loss, and nail problems.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

A patient experienced permanent hair loss due to an allergic reaction to a corticosteroid injection.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

A man's neck lump was a trichilemmal cyst, not cancer, and should be fully removed due to rare risk of becoming malignant.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

More men have androgenic alopecia than women, with stress linked to the condition in both genders.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

A 15-year-old boy had a rare skin growth on his buttock.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

A woman had a cyst in her salivary gland, likely from Botox, which was removed and confirmed as an epidermoid cyst.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Acitretin significantly reduced inflammatory attacks in a woman with Naevus Comedonicus Syndrome but caused side effects.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Rare seminoma found in a 33-year-old woman with atypical genitalia and no Y chromosome.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

CRH causes hair loss by reducing autophagy and increasing cell death in hair cells.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

Cronkhite-Canada syndrome is a rare condition causing gut polyps, hair loss, skin changes, and nail issues, often with a poor outlook.